{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:49:22Z","timestamp":1761580162584},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.npep.2003.09.003","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T14:24:37Z","timestamp":1068128677000},"page":"345-354","source":"Crossref","is-referenced-by-count":14,"title":["Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists"],"prefix":"10.1016","volume":"37","author":[{"given":"Nadine","family":"Michaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9jean","family":"Couture","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2003.09.003_BIB1","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0006-291X(05)80041-5","article-title":"Neurokinin A (NK2) receptor revisited with SR48968, a potent non-peptide antagonist","volume":"184","author":"Advenier","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.npep.2003.09.003_BIB2","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/0024-3205(84)90530-7","article-title":"Substance P levels in various regions of the rat central nervous system after acute and chronic morphine treatment","volume":"35","author":"Bergstr\u00f6m","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2003.09.003_BIB3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1440-1681.1987.tb01883.x","article-title":"Plasma catecholamine concentrations during morphine withdrawal in conscious guinea-pigs","volume":"14","author":"Brent","year":"1987","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.npep.2003.09.003_BIB4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0361-9230(97)00013-0","article-title":"Effect of intrathecal pretreatment with the neurokinin receptor antagonist CP-99994 on the expression of naloxone-precipitated morphine withdrawal symptoms","volume":"43","author":"Buccafusco","year":"1997","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.npep.2003.09.003_BIB5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bjp.0702620","article-title":"Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat","volume":"127","author":"Cellier","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2003.09.003_BIB6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.bjp.0701435","article-title":"Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat","volume":"122","author":"Cellier","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2003.09.003_BIB7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(98)00984-4","article-title":"Cardiovascular changes during morphine administration and spontaneous withdrawal in the rat","volume":"368","author":"Chan","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2003.09.003_BIB8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0024-3205(99)00561-5","article-title":"SR142801 behaves as a tachykinin NK-3 receptor agonist on a spinal nociceptive reflex in the rat","volume":"66","author":"Couture","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2003.09.003_BIB9","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1139\/y95-123","article-title":"Characterization of the tachykinin receptors involved in spinal and supraspinal cardiovascular regulation","volume":"73","author":"Couture","year":"1995","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.npep.2003.09.003_BIB10","first-page":"547","article-title":"Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system","volume":"340","author":"Couture","year":"1989","journal-title":"Naunyn-Schm. Arch. Pharmacol."},{"key":"10.1016\/j.npep.2003.09.003_BIB11","first-page":"238","article-title":"Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress","volume":"280","author":"Culman","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2003.09.003_BIB12","doi-asserted-by":"crossref","first-page":"PL27","DOI":"10.1016\/0024-3205(94)00413-M","article-title":"SR142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor","volume":"56","author":"Emonds-Alt","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2003.09.003_BIB13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0024-3205(92)90352-P","article-title":"A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor","volume":"50","author":"Emonds-Alt","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2003.09.003_BIB14","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archinte.1942.00200170048004","article-title":"Clinical studies of drug addiction: physical dependence, withdrawal and recovery","volume":"69","author":"Himmelsbach","year":"1942","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.npep.2003.09.003_BIB15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1021\/jm950616c","article-title":"3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonists","volume":"39","author":"Hipskind","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.npep.2003.09.003_BIB16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0014-2999(92)90485-M","article-title":"Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats","volume":"219","author":"Itoi","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2003.09.003_BIB17","first-page":"283","article-title":"Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs","volume":"343","author":"Johnston","year":"1991","journal-title":"Naunyn-Schm. Arch. Pharmacol."},{"key":"10.1016\/j.npep.2003.09.003_BIB18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0167-0115(93)90091-L","article-title":"Neurokinin-1, -2 and -3 receptors are candidates for a role in the opiate withdrawal response in guinea-pigs","volume":"46","author":"Johnston","year":"1993","journal-title":"Regul. Peptides"},{"key":"10.1016\/j.npep.2003.09.003_BIB19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1176\/ajp.94.4.759","article-title":"Clinical studies of drug addiction, III. A critical review of the withdrawal treatments with method of evaluating abstinence syndromes","volume":"94","author":"Kolb","year":"1938","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.npep.2003.09.003_BIB20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0143-4179(98)90019-1","article-title":"Changes in oxytocin content in rat brain during morphine withdrawal","volume":"32","author":"Laorden","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2003.09.003_BIB21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00421382","article-title":"Sites of action of morphine involved in the development of physical dependence in rats. I. Comparison of precipitated morphine withdrawal after intraperitoneal and intraventricular injection of morphine antagonists","volume":"46","author":"Laschka","year":"1976","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.npep.2003.09.003_BIB22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00421383","volume":"46","author":"Laschka","year":"1976","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.npep.2003.09.003_BIB23","unstructured":"Lessard, A., Couture, R., 2001. Anti-hypertensive effect induced by intracerebral injection of tachykinin NK-3 receptor antagonists in hypertensive rats. In: 31st Annual Meeting of Society for Neuroscience, San Diego, CA, USA, November 10\u201315, 2001 (Abstract 837.7)"},{"key":"10.1016\/j.npep.2003.09.003_BIB24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/cimm.2000.1713","article-title":"Morphine up-regulates expression of substance P and its receptor in human blood mononuclear phagocytes and lymphocytes","volume":"205","author":"Li","year":"2000","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.npep.2003.09.003_BIB25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0306-4522(00)00226-8","article-title":"Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons","volume":"99","author":"Ma","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2003.09.003_BIB26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1474-8673.1993.tb00396.x","article-title":"Tachykinin receptors and tachykinin receptor antagonists","volume":"13","author":"Maggi","year":"1993","journal-title":"J. Auton. Pharmacol."},{"key":"10.1016\/j.npep.2003.09.003_BIB27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0304-3940(93)90457-V","article-title":"RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats","volume":"156","author":"Maldonado","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2003.09.003_BIB28","first-page":"669","article-title":"Role of different brain structures in the expression of the physical morphine withdrawal syndrome","volume":"61","author":"Maldonado","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2003.09.003_BIB29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0006-8993(85)90518-9","article-title":"Supraspinal and spinal mediation of naloxone-induced morphine withdrawal in rats","volume":"329","author":"Marshall","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2003.09.003_BIB30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00408180","article-title":"Tolerance to and physical dependence on morphine in rats","volume":"4","author":"Martin","year":"1963","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.npep.2003.09.003_BIB31","unstructured":"Michaud, N., 2001. Implication des r\u00e9cepteurs centraux des tachykinines lors d\u2019un sevrage \u00e0 la morphine chez le rat. M.Sc. Thesis, Universit\u00e9 de Montr\u00e9al, pp. 1\u2013104"},{"key":"10.1016\/j.npep.2003.09.003_BIB32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0306-4522(91)90318-I","article-title":"Intraspinal release of substance P and calcitonin gene-related peptide during opiate dependence and withdrawal","volume":"43","author":"Morton","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2003.09.003_BIB33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/35012069","article-title":"Rewarding effects of opiates are absent in mice lacking the receptor for substance P","volume":"405","author":"Murtra","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.npep.2003.09.003_BIB34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1152\/physrev.1993.73.2.229","article-title":"Neurotransmitter functions of mammalian tachykinins","volume":"73","author":"Otsuka","year":"1993","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.npep.2003.09.003_BIB35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1476-5381.1994.tb13058.x","article-title":"Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists","volume":"112","author":"Picard","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2003.09.003_BIB36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.bjp.0703655","article-title":"Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists","volume":"131","author":"Powell","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2003.09.003_BIB37","first-page":"551","article-title":"Receptors and antagonists for substance P and related peptides","volume":"46","author":"Regoli","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.npep.2003.09.003_BIB38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3940(86)90561-6","article-title":"Neonatal capsaicin modifies morphine withdrawal signs in the rat","volume":"71","author":"Sharpe","year":"1986","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.npep.2003.09.003_BIB39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0024-3205(83)90521-0","article-title":"Morphine tolerance and withdrawal in capsaicin-pretreated rats","volume":"33","author":"Szikszay","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2003.09.003_BIB40","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1523\/JNEUROSCI.19-21-09642.1999","article-title":"Spinal opioid analgesia: how critical is the regulation of substance P signaling ?","volume":"19","author":"Trafton","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2003.09.003_BIB41","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1476-5381.1992.tb14518.x","article-title":"Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat","volume":"107","author":"Tsch\u00f6pe","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2003.09.003_BIB42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0006-8993(87)90487-2","article-title":"Excess release of substance P from the spinal cord of mice during morphine withdrawal and involvement of the enhancement of presynaptic Ca2+ entry","volume":"425","author":"Ueda","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2003.09.003_BIB43","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/01.RES.63.4.812","article-title":"Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization","volume":"63","author":"Unger","year":"1988","journal-title":"Circ. Res."},{"key":"10.1016\/j.npep.2003.09.003_BIB44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00429002","article-title":"Inhibition of shaking movements in rats by central administration of cholinergic and adrenergic agents","volume":"81","author":"Wei","year":"1983","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.npep.2003.09.003_BIB45","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0028-3908(98)00128-2","article-title":"Alteration in the brain content of substance P (1\u20137) during withdrawal in morphine-dependent rats","volume":"37","author":"Zhou","year":"1998","journal-title":"Neuropharmacology"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014341790300091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014341790300091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T16:17:09Z","timestamp":1585239429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014341790300091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S014341790300091X"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2003.09.003","relation":{},"ISSN":["0143-4179"],"issn-type":[{"type":"print","value":"0143-4179"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}